Literature DB >> 33552957

A Novel Prognostic Scoring System of Intrahepatic Cholangiocarcinoma With Machine Learning Basing on Real-World Data.

Zhizhen Li1, Lei Yuan1, Chen Zhang2, Jiaxing Sun3, Zeyuan Wang4, Yu Wang5, Xin Hao5, Fei Gao3, Xiaoqing Jiang1.   

Abstract

BACKGROUND AND OBJECTIVES: Currently, the prognostic performance of the staging systems proposed by the 8th edition of the American Joint Committee on Cancer (AJCC 8th) and the Liver Cancer Study Group of Japan (LCSGJ) in resectable intrahepatic cholangiocarcinoma (ICC) remains controversial. The aim of this study was to use machine learning techniques to modify existing ICC staging strategies based on clinical data and to demonstrate the accuracy and discrimination capacity in prognostic prediction. PATIENTS AND METHODS: This is a retrospective study based on 1,390 patients who underwent surgical resection for ICC at Eastern Hepatobiliary Surgery Hospital from 2007 to 2015. External validation was performed for patients from 2015 to 2017. The ensemble of three machine learning algorithms was used to select the most important prognostic factors and stepwise Cox regression was employed to derive a modified scoring system. The discriminative ability and predictive accuracy were assessed using the Concordance Index (C-index) and Brier Score (BS). The results were externally validated through a cohort of 42 patients operated on from the same institution.
RESULTS: Six independent prognosis factors were selected and incorporated in the modified scoring system, including carcinoembryonic antigen, carbohydrate antigen 19-9, alpha-fetoprotein, prealbumin, T and N of ICC staging category in 8th edition of AJCC. The proposed scoring system showed a more favorable discriminatory ability and model performance than the AJCC 8th and LCSGJ staging systems, with a higher C-index of 0.693 (95% CI, 0.663-0.723) in the internal validation cohort and 0.671 (95% CI, 0.602-0.740) in the external validation cohort, which was then confirmed with lower BS (0.103 in internal validation cohort and 0.169 in external validation cohort). Meanwhile, machine learning techniques for variable selection together with stepwise Cox regression for survival analysis shows a better prognostic accuracy than using stepwise Cox regression method only.
CONCLUSIONS: This study put forward a modified ICC scoring system based on prognosis factors selection incorporated with machine learning, for individualized prognosis evaluation in patients with ICC.
Copyright © 2021 Li, Yuan, Zhang, Sun, Wang, Wang, Hao, Gao and Jiang.

Entities:  

Keywords:  intrahepatic cholangiocarcinoma; machine learning; overall survival; prognosis; staging system

Year:  2021        PMID: 33552957      PMCID: PMC7855854          DOI: 10.3389/fonc.2020.576901

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  38 in total

1.  Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein.

Authors:  Yan-Ming Zhou; Jia-Mei Yang; Bin Li; Zheng-Feng Yin; Feng Xu; Bin Wang; Peng Liu; Zhi-Min Li
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

2.  Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma.

Authors:  Gaya Spolverato; Fabio Bagante; Matthew Weiss; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Oliver Soubrane; Guillaume Martel; Bas Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Surg Oncol       Date:  2017-02-14       Impact factor: 3.454

3.  Serum tumor markers enhance the predictive power of the AJCC and LCSGJ staging systems in resectable intrahepatic cholangiocarcinoma.

Authors:  Kazunari Sasaki; Georgios A Margonis; Nikolaos Andreatos; Qinyu Chen; Carlotta Barbon; Fabio Bagante; Matthew Weiss; Irinel Popescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Olivier Soubrane; Guillaume Martel; Bas Groot Koerkamp; Alfredo Guglielmi; Itaru Endo; Federico N Aucejo; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2018-06-08       Impact factor: 3.647

Review 4.  General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan.

Authors:  Masatoshi Kudo; Masayuki Kitano; Toshiharu Sakurai; Naoshi Nishida
Journal:  Dig Dis       Date:  2015-10-21       Impact factor: 2.404

5.  The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma.

Authors:  Manuel Jaklitsch; Henrik Petrowsky
Journal:  Transl Gastroenterol Hepatol       Date:  2019-04-04

6.  Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis.

Authors:  Yuhree Kim; Dimitrios P Moris; Xu-Feng Zhang; Fabio Bagante; Gaya Spolverato; Carl Schmidt; Mary Dilhoff; Timothy M Pawlik
Journal:  J Surg Oncol       Date:  2017-06-12       Impact factor: 3.454

7.  Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Tommaso Campagnaro; Silvia Pachera; Alessandro Valdegamberi; Paola Nicoli; Alessandro Cappellani; Giulio Malfermoni; Calogero Iacono
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

8.  Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.

Authors:  Hauke Lang; Georgios C Sotiropoulos; George Sgourakis; Klaus J Schmitz; Andreas Paul; Philip Hilgard; Thomas Zöpf; Tanja Trarbach; Massimo Malagó; Hideo A Baba; Christoph E Broelsch
Journal:  J Am Coll Surg       Date:  2009-02       Impact factor: 6.113

9.  What prognostic factors are important for resected intrahepatic cholangiocarcinoma?

Authors:  Kwang Yeol Paik; Jun Chul Jung; Jin Seok Heo; Seong Ho Choi; Dong Wook Choi; Yong Il Kim
Journal:  J Gastroenterol Hepatol       Date:  2007-09-12       Impact factor: 4.029

10.  Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.

Authors:  Supriya K Saha; Andrew X Zhu; Charles S Fuchs; Gabriel A Brooks
Journal:  Oncologist       Date:  2016-03-21
View more
  3 in total

Review 1.  Artificial intelligence and cholangiocarcinoma: Updates and prospects.

Authors:  Hossein Haghbin; Muhammad Aziz
Journal:  World J Clin Oncol       Date:  2022-02-24

2.  Predicting Lapatinib Dose Regimen Using Machine Learning and Deep Learning Techniques Based on a Real-World Study.

Authors:  Ze Yu; Xuan Ye; Hongyue Liu; Huan Li; Xin Hao; Jinyuan Zhang; Fang Kou; Zeyuan Wang; Hai Wei; Fei Gao; Qing Zhai
Journal:  Front Oncol       Date:  2022-06-03       Impact factor: 5.738

3.  Survival Prediction in Intrahepatic Cholangiocarcinoma: A Proof of Concept Study Using Artificial Intelligence for Risk Assessment.

Authors:  Lukas Müller; Aline Mähringer-Kunz; Simon Johannes Gairing; Friedrich Foerster; Arndt Weinmann; Fabian Bartsch; Lisa-Katharina Heuft; Janine Baumgart; Christoph Düber; Felix Hahn; Roman Kloeckner
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.